Assessment of the bioactive conformation of the vasoactive intestinal peptide by computational methods

被引:1
作者
Filizola, M
Perez, JJ
机构
[1] UPC, Dept Engn Quim, Barcelona 08028, Spain
[2] ETS Enginyers Ind, Barcelona 08028, Spain
[3] Mol Res Inst, Mountain View, CA 94043 USA
关键词
vasoactive intestinal peptide; VIP; VIP analogs; conformational analysis; bioactive conformation; AMBER force field;
D O I
10.1002/qua.10112
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In the present work, we report the results of a computational study aimed at assessing the structural features of the bioactive conformation of the vasoactive intestinal peptide (VIP). Based on previous structure-activity studies the present work reports the results of a comparative analysis of the conformational profiles of the segments 1-11 of the native peptide, two VIP antagonists and two inactive analogs. All these analogs exhibit the same sequence as VIP at C-terminus and only differ in some of the amino acids of the N-terminus. Analogs selected for the present study include VIP(7-28) fused to neurotensin (6-11) (Met-hydrid) and [Ac-Tyr(1), D-Phe(2)]-VIP (both antagonists) and [Ala(3)]-VIP and [Ala(6)]-VIP (two inactive analogs). The conformational space of the five peptides was thoroughly explored using simulated annealing in an iterative fashion as sampling technique. The bioactive conformation was selected from pairwise cross-comparisons between each of the unique low energy conformations found for VIP(1-11) and each of the different analogs, within a 3 kcal/mol threshold in regard of the respective lowest energy conformation characterized. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:201 / 210
页数:10
相关论文
共 36 条
  • [1] RECEPTORS FOR VASOACTIVE INTESTINAL PEPTIDE AND SECRETIN ON RAT PANCREATIC ACINI
    BISSONNETTE, BM
    COLLEN, MJ
    ADACHI, H
    JENSEN, RT
    GARDNER, JD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (06): : G710 - G717
  • [2] DESIGN AND DEVELOPMENT OF A VASOACTIVE-INTESTINAL-PEPTIDE ANALOG AS A NOVEL THERAPEUTIC FOR BRONCHIAL-ASTHMA
    BOLIN, DR
    MICHALEWSKY, J
    WASSERMAN, MA
    ODONNELL, M
    [J]. BIOPOLYMERS, 1995, 37 (02) : 57 - 66
  • [3] Brand SJ, 1995, TXB GASTROENTEROLOGY, P25
  • [4] THE QUEST FOR THE INHIBITORY NEUROTRANSMITTER IN BOVINE TRACHEAL SMOOTH-MUSCLE
    CAMERON, AR
    JOHNSTON, CF
    KIRKPATRICK, CT
    KIRKPATRICK, MCA
    [J]. QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1983, 68 (03): : 413 - 426
  • [5] CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175
  • [6] ISOLATION AND AMINO-ACID-COMPOSITION OF HUMAN VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)
    CARLQUIST, M
    MCDONALD, TJ
    GO, VLW
    BATAILLE, D
    JOHANSSON, C
    MUTT, V
    [J]. HORMONE AND METABOLIC RESEARCH, 1982, 14 (01) : 28 - 29
  • [7] CHAKDER S, 1993, J PHARMACOL EXP THER, V266, P392
  • [8] Evaluation of the iterative simulated annealing technique in conformational search of peptides
    Corcho, FJ
    Filizola, M
    Pérez, JJ
    [J]. CHEMICAL PHYSICS LETTERS, 2000, 319 (1-2) : 65 - 70
  • [9] Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
    Delgado, M
    Abad, C
    Martinez, C
    Laceta, J
    Gomariz, RP
    [J]. NATURE MEDICINE, 2001, 7 (05) : 563 - 568
  • [10] DONNELL M, 1991, J BIOL CHEM, V266, P6389